Dyslipidaemia is a hallmark of chronic kidney disease (CKD). The severity of dyslipidaemia
not only correlates with CKD stage but is also associated with CKD-associated …

Background. L-carnitine has been used for several years as an adjuvant therapy in oxidative
stress, blood sugar, high-sensitivity C-reactive protein (CRP), anemia, etc. However, the …

Objective Limited data are available for evaluating the effects of oral carnitine
supplementation on weight loss and metabolic profiles of women with polycystic ovary …

Carnitine is a naturally occurring amino acid derivative that is involved in the transport of
long-chain fatty acids to the mitochondrial matrix. There, these substrates undergo β …

Background and aim l-carnitine has an important role in fatty acid metabolism and could
therefore act as an adjuvant agent in the improvement of dyslipidemia. The purpose of …

Purpose Polycystic ovary syndrome (PCOS) is a common endocrine disorder among
reproductive-age women. Insulin resistance and dyslipidemia are linked to PCOS. l …

Background: A previous meta-analysis indicated that l-carnitine significantly increased
hemoglobin and decreased the required erythropoietin dose in maintenance hemodialysis …

Background L-carnitine (LC) plays an important physiologic role in lipid metabolism. To
date, no clinical study has been performed to examine the effect of LC supplementation on …

Materials and Methods: This study was conducted using authentic Persian and English
keywords in the national and international databases including IranMedex, SID, Magiran …

To evaluate the reproductive and metabolic effects of L-carnitine plus metformin in
clomiphene citrate (CC) resistant obese polycystic ovary syndrome (PCOS) women. A …